Skip to main content

चार विद्रोही संत, एक ही सच

Cobra Snakebite First Aid: Can Heparin Help Prevent Severe Damage?

Every year, thousands of people suffer severe injuries from cobra bites, often resulting in limb amputations. A recent study has revealed that a common blood-thinning medication called heparin may help reduce these serious consequences. Snakebites cause around 138,000 deaths globally each year, most commonly in Sub-Saharan Africa and Southeast Asia. Beyond fatalities, over 400,000 survivors face complications such as tissue death, often requiring amputation.

Scientists at the University of Sydney, led by Tian Du, found that cobra venom targets a molecule called heparan sulfate on the surface of human cells. Heparin, which is naturally produced by certain immune cells and is widely used in medicine, can block this harmful interaction. In laboratory tests involving venom from the red spitting cobra (Naja pallida) and black-necked spitting cobra (Naja nigricollis), researchers found that adding heparin to human skin and blood cells significantly reduced cell death. Similar protective results were observed in mouse models, where heparin decreased the risk of tissue necrosis.

This discovery suggests that heparin could serve as a broad-spectrum treatment for various types of cobra bites. One major advantage of heparin is its stability at room temperature, making it a practical candidate for emergency treatment—possibly even via a device like an EpiPen.

Still, questions remain. The long-term effectiveness of heparin post-bite has not yet been fully studied, and experts such as Geoff Isbister from the University of Newcastle emphasize that this research didn’t compare heparin directly with traditional antivenoms, which are also highly effective when given quickly.

Until further testing is complete, antivenom remains the standard treatment. However, if someone is bitten by a cobra and medical care is not immediately accessible, administering a small dose of heparin (if available and no known allergy exists) may provide temporary protection against rapid tissue damage. This does not replace medical treatment but could buy crucial time until professional care is available. Always seek emergency help after a snakebite, but this research offers hope for improved outcomes and a new use for a familiar drug.



Popular posts from this blog

चार विद्रोही संत, एक ही सच

चार विद्रोही संत – एक ही सच | Osho, Kabir, Krishnamurti और Acharya Prashant की सोच “सत्य कोई मार्ग नहीं है, यह मार्गहीन है।” – J. Krishnamurti “मस्जिद ढायो, मंदर ढायो, मन का दंभ न ढायो?” – Kabir “धर्म एक ज़हर है, जो तुम्हारे भीतर की खोज को मार देता है।” – Osho “जहाँ भीड़ है, वहाँ सत्य नहीं हो सकता।” – Acharya Prashant चार अलग-अलग युग, चार अलग-अलग संत… लेकिन एक ही विद्रोही आत्मा। 🧠 यह लेख क्यों पढ़ें? यदि आपने कभी Osho की बातें सुनी हैं, Kabir के दोहे से चौंके हैं, Krishnamurti के दर्शन से सोच में डूबे हैं या Acharya Prashant की आवाज़ से हिले हैं — तो यह लेख आपको वह गहरा पुल दिखाएगा, जो इन चार विद्रोही आत्माओं को जोड़ता है। 🔥 एक विद्रोह, चार चेहरे 1. Kabir: शब्दों से युद्ध 15वीं सदी का वह जुलाहा, जिसने अपने दोहों से ब्राह्मणवाद और पाखंड पर सीधी चोट की। “पढ़ि पढ़ि पंडित मूढ़ भया, पढ़ि पढ़ि भया गधेराम।” Kabir की भाषा आम थी, लेकिन विचार परम थे। 2. Krishnamurti: सोच का विस्फोट 20वीं सदी का वह विचारक जिसने कहा: “सत्य कोई संगठन नहीं बन सकता। न ही यह किसी ...

Weight loss and diabetes medications help reduce alcohol addiction.

A recent study has found that people taking medications like Ozempic and Wegovy for diabetes or weight loss are less likely to develop alcohol addiction. The study, conducted on around 700,000 individuals who had taken these drugs, suggests that they may also be beneficial for people dealing with various types of addiction. Ozempic and Wegovy mimic the hormone GLP-1, which is normally released after eating. This hormone reduces appetite and increases insulin, which helps regulate blood sugar levels. Previous animal studies had shown that these drugs could reduce alcohol intake, and now this large human study confirms similar results. Rong Xu and her team at Case Western Reserve University in Cleveland, Ohio, analyzed the health records of about 84,000 people who were taking either semaglutide or another type of anti-obesity medication. They found that people on semaglutide were half as likely to be diagnosed with alcohol addiction. The same pattern was observed in a separate analysis o...